Yossi Peled
Chairman
Claimed by owner NextFerm
Former names:
Non-GMO Yeast Products
Public on TASE Jan, 2021
NextFerm
www.themarker.com
•
Mar 1, 2023
נקסטפרם מגייסת 54 מיליון שקל בהנפקה; המניה צוללת ב-64%
seenews.com
•
Dec 5, 2022
Israel's NextFerm to open factory in N. Macedonia - report
www.foodnavigator-usa.com
•
Sep 9, 2022
NextFerm announces production deal for yeast-derived vegan protein
www.sponser.co.il
•
Jun 19, 2022
נקסטפרם טכנולוגיות מודיעה על תחילת ייצור מסחרי של ™ProteVin תחליף החלבון הטבעוני שלה
en.globes.co.il
•
Jan 26, 2021
Food-tech co NextFerm completes TASE IPO
www.nutritionaloutlook.com
•
Feb 6, 2020
NextFerm and Soft Gel Technologies collaborate to launch new astaxanthin ingredient
www.nutritionaloutlook.com
•
Jan 28, 2020
NextFerm announces new patent application for yeast-based astaxanthin
www.nutraceuticalbusinessreview.com
•
Oct 8, 2019
NextFerm Technologies files patent for astaxanthin-producing yeast strains
www.jpost.com
•
Sep 9, 2019
https://www.jpost.com/Israel-News/Israeli-firm-turns-to-yeast-to-revolutionize-the-fake-meat-market-600745
en.globes.co.il
•
Aug 19, 2019
The super yeasts producing protein and fuel
www.nutraingredients-usa.com
•
Nov 14, 2018
Israeli startup debuts astaxanthin from yeast for human consumption
www.biofuelsdigest.com
•
Sep 24, 2018
Mascoma and NextFerm team up on yeast innovations for biofuels
www.nutraingredients-usa.com
•
Jun 1, 2018
Israeli startup aims to make splash with fermentation technology
About
NextFerm develops and produces active ingredients for the food industry. Its products are based on a combination of intellectual property and proprietary know-how in areas including non-GMO technologies and methodologies for enhancing specific characteristics of yeast strains isolated from nature; downstream processing, purification, extraction, and formulation; and clinical research and regulatory work.
The company is currently producing natural astaxanthin from yeast fermentation for human nutrition, implementing its yeast strain improvement technology on a strain that naturally expresses astaxanthin in order to make it a better source. Coupled with downstream engineering and clinical work, this technology results in a product with higher potency, improved flowability, and no odor or flavor in either liquid or powder form.
NextFerms goal is to develop exclusive active ingredients for the global nutrition market, including carotenoids, prebiotics, and proteins. In addition, NextFerm has developed a novel yeast strain for more efficient production of ethanol from corn mash.
The company is currently producing natural astaxanthin from yeast fermentation for human nutrition, implementing its yeast strain improvement technology on a strain that naturally expresses astaxanthin in order to make it a better source. Coupled with downstream engineering and clinical work, this technology results in a product with higher potency, improved flowability, and no odor or flavor in either liquid or powder form.
NextFerms goal is to develop exclusive active ingredients for the global nutrition market, including carotenoids, prebiotics, and proteins. In addition, NextFerm has developed a novel yeast strain for more efficient production of ethanol from corn mash.
Primary Sector
AgriFood-tech & Water
Products
AstaFerm, NextFreeze, ProteVin
Geographic markets
United States, Global
Funding
Total Funding
$9.18M
Market Cap
$997.82K
Last Funding
$9.18M
Funding Stage
Total Rounds
1
Investors
0
News
(13)
www.themarker.com
•
Mar 1, 2023
נקסטפרם מגייסת 54 מיליון שקל בהנפקה; המניה צוללת ב-64%
seenews.com
•
Dec 5, 2022
Israel's NextFerm to open factory in N. Macedonia - report
www.foodnavigator-usa.com
•
Sep 9, 2022
NextFerm announces production deal for yeast-derived vegan protein
www.sponser.co.il
•
Jun 19, 2022
נקסטפרם טכנולוגיות מודיעה על תחילת ייצור מסחרי של ™ProteVin תחליף החלבון הטבעוני שלה
en.globes.co.il
•
Jan 26, 2021
Food-tech co NextFerm completes TASE IPO
www.nutritionaloutlook.com
•
Feb 6, 2020
NextFerm and Soft Gel Technologies collaborate to launch new astaxanthin ingredient
www.nutritionaloutlook.com
•
Jan 28, 2020
NextFerm announces new patent application for yeast-based astaxanthin
www.nutraceuticalbusinessreview.com
•
Oct 8, 2019
NextFerm Technologies files patent for astaxanthin-producing yeast strains
www.jpost.com
•
Sep 9, 2019
https://www.jpost.com/Israel-News/Israeli-firm-turns-to-yeast-to-revolutionize-the-fake-meat-market-600745
en.globes.co.il
•
Aug 19, 2019
The super yeasts producing protein and fuel
www.nutraingredients-usa.com
•
Nov 14, 2018
Israeli startup debuts astaxanthin from yeast for human consumption
www.biofuelsdigest.com
•
Sep 24, 2018
Mascoma and NextFerm team up on yeast innovations for biofuels
www.nutraingredients-usa.com
•
Jun 1, 2018
Israeli startup aims to make splash with fermentation technology
The Team
(7)
YP
Elzaphan Hotam
CEO of NextFerm Technologies USA & VP Global Marketing
BN
Boaz Noy
Co-founder & CEO
TC
Tzafra Cohen
Co-founder, SVP R&D & BD
YO
Yossi Ohana
CFO
YT
Yoni Twito
COO
AH
Arkadiy Haikin
CSO
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Public Offerings & Exits
Initial Public Offering
EXIT
$9.18M
Jan 2021
Stock Exchange
TASE
Valuation
$35.1M
$9.18M
Media gallery
(5)
AstaFerm Beadlets technology introduced
Evolution in a tube: astaxnathin expression through multiple yeast generations
The first fermented astaxanthin
Locations
Israel
HaKidma St 7, Yokne'am Illit, Israel
Offices Abroad
100 Connell Drive, Berkeley Heights, NJ 07922, USA
Locations
Israel
HaKidma St 7, Yokne'am Illit, Israel
Offices Abroad
100 Connell Drive, Berkeley Heights, NJ 07922, USA
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,